BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1365918)

  • 1. Mucins: structure, function, and associations with malignancy.
    Devine PL; McKenzie IF
    Bioessays; 1992 Sep; 14(9):619-25. PubMed ID: 1365918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
    Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
    Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoma associated mucins: molecular biology and clinical applications.
    Verma M
    Cancer Biochem Biophys; 1994 Oct; 14(3):151-62. PubMed ID: 7728736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid.
    Devine PL; Clark BA; Birrell GW; Layton GT; Ward BG; Alewood PF; McKenzie IF
    Cancer Res; 1991 Nov; 51(21):5826-36. PubMed ID: 1718585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product.
    Burchell J; Taylor-Papadimitriou J
    Epithelial Cell Biol; 1993 Oct; 2(4):155-62. PubMed ID: 7505698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody.
    Baeckström D; Nilsson O; Price MR; Lindholm L; Hansson GC
    Cancer Res; 1993 Feb; 53(4):755-61. PubMed ID: 7679050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate antigens on cancer-associated mucin-like molecules.
    Ho SB; Kim YS
    Semin Cancer Biol; 1991 Dec; 2(6):389-400. PubMed ID: 1725730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy.
    Taylor-Papadimitriou J; Epenetos AA
    Trends Biotechnol; 1994 Jun; 12(6):227-33. PubMed ID: 7765069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucin glycoproteins as tumor markers.
    Feller WF; Henslee JG; Kinders RJ; Manderino GL; Tomita JT; Rittenhouse HG
    Immunol Ser; 1990; 53():631-72. PubMed ID: 2100576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucin-type glycoproteins.
    Strous GJ; Dekker J
    Crit Rev Biochem Mol Biol; 1992; 27(1-2):57-92. PubMed ID: 1727693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mucin antigens: what are we measuring?
    Price MR; Briggs S; Scanlon MJ; Tendler SJ; Sibley PE; Hand CW
    Dis Markers; 1991; 9(3-4):205-12. PubMed ID: 1725974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer associated mucin: a review.
    Segal-Eiras A; Croce MV
    Allergol Immunopathol (Madr); 1997; 25(4):176-81. PubMed ID: 9269507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and biosynthesis of human salivary mucins.
    Zalewska A; Zwierz K; Zółkowski K; Gindzieński A
    Acta Biochim Pol; 2000; 47(4):1067-79. PubMed ID: 11996097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human models of breast cancer.
    Taylor-Papadimitriou J; Berdichevsky F; D'Souza B; Burchell J
    Cancer Surv; 1993; 16():59-78. PubMed ID: 8348539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
    Hanisch FG; Stadie T; Bosslet K
    Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrates in oral epithelia and secretions: variation with cellular differentiation.
    Mandel U
    APMIS Suppl; 1992; 27():119-29. PubMed ID: 1520521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to peptide regions of a surface mucin (MUC1) is reduced by sialic acids.
    Ho JJ; Cheng S; Kim YS
    Biochem Biophys Res Commun; 1995 May; 210(3):866-73. PubMed ID: 7539263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin.
    Ho JJ; Bi N; Yan PS; Yuan M; Norton KA; Kim YS
    Cancer Res; 1991 Jan; 51(1):372-80. PubMed ID: 1703039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MUC1, a therapeutic target in oncology].
    Limacher JM; Acres B
    Bull Cancer; 2007 Mar; 94(3):253-7. PubMed ID: 17371767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human B cell immune response to selected epitopes of the polymorphic epithelial mucin (PEM) in cancer patients.
    Nuti M; Rughetti A; Turchi V; Apollonj-Ghetti C; Scambia G; Frati L
    In Vivo; 1993; 7(6B):645-7. PubMed ID: 7514896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.